Caspase-2, the most evolutionarily conserved member of the caspase family, has been shown to be involved in apoptosis induced by various stimuli. Our recent work indicates that caspase-2 has putative functions in tumor suppression and protection against cellular stress. As such, the loss of caspase-2 enhances lymphomagenesis in Eμ-Myc transgenic mice, and caspase-2 KO (Casp2 
T he physiological functions of caspase-2 have remained elusive since its discovery two decades ago (1) (2) (3) . This is partly because of the lack of a clear phenotype in caspase-2 KO (Casp2 −/− ) mice that display only minor, tissue-specific apoptosis defects (4) . We have previously demonstrated that loss of caspase-2 accelerates lymphomagenesis in Eμ-Myc transgenic mice, providing experimental evidence for a tumor suppressor function for caspase-2 (5). Consistent with a role in tumor suppression, loss of caspase-2 expression and function has been detected in various human cancers and has been associated with poor prognosis and drug resistance (6) . From our previous work, we have also demonstrated that caspase-2-deficient mouse embryonic fibroblasts (MEFs) display aberrant proliferation, persistent DNA damage, and cell cycle checkpoint defects (7) . Furthermore, Casp2
−/− MEFs and lymphomas derived from Eμ-Myc/Casp2 −/− mice exhibit increased aneuploidy, suggesting that caspase-2 is important for the maintenance of genomic stability (7) . Our previous studies indicate that attenuated p53 induction and activity observed in Casp2 −/− MEFs following DNA damage may contribute to these defects (7) .
Strict regulation of cell cycle progression and preservation of genomic integrity are essential for maintaining cell homeostasis and preventing cell transformation (8) . This is exemplified in cancer cells, which frequently display elevated levels of basal DNA damage, chromosomal instability, and aberrant proliferation (9) . To protect against these detrimental effects, cells have evolved complex tumor suppressor networks to eliminate potentially malignant cells and prevent the transmission of mutations (8) . Ataxia telangiectasia (A-T) mutated (ATM) kinase is a core component of these pathways and has an essential role in sensing DNA double-strand breaks and transducing downstream signals that activate the DNA repair and cell cycle checkpoint machinery (10) . ATM has also been shown to be directly activated by oxidative stress through a mechanism distinct to that of activation by DNA breaks (11) . Upon activation by reactive oxygen species (ROS), ATM stimulates the production of NADPH, thereby regulating cellular redox homeostasis during oxidative insult (12) . Interestingly,
Casp2
−/− mice show premature aging-related traits, including oxidative tissue damage and a reduced ability to tolerate stress, implicating caspase-2 in the regulation of the antioxidant stress response (13, 14) .
There is mounting evidence that the tumor suppressor function of caspase-2 is linked to its roles in the DNA damage response (DDR), oxidative defense system, and the maintenance of genomic stability (6) . Given the overlapping functions of ATM and caspase-2 in these processes, we generated Atm/caspase-2 double KO (Atm
−/− ) mice to investigate whether caspase-2 and ATM genetically and functionally interact in tumor suppression and genome surveillance. Atm −/− mice recapitulate many clinical features of the rare human disease A-T, such as growth retardation, infertility, and hypersensitivity to ionizing radiation (15, 16) . As in patients with A-T, Atm −/− mice are also prone to spontaneous lymphomagenesis (15, 16) .
Here we show that caspase-2 deficiency exacerbates somatic growth retardation in Atm − /− mice. Importantly, we found that loss of caspase-2 dramatically increases the incidence of
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Casp2
−/− fetuses were present at the expected Mendelian ratios (Table 1) . Furthermore, Atm
fetuses were alive at E18.5 as determined by their response to toepinch stimulus. These observations indicate that Atm
offspring die soon after birth. To assess the reason for this lethality, we carefully examined serial sections of E18.5 Atm
, and WT fetuses. We failed to see any specific phenotype in Atm
−/− fetuses (Figs. S1 and S2).
To assess somatic animal growth, WT,
, and Atm −/− Casp2 −/− mice were weighed weekly from 2 to 18 wk of age. Consistent with previous studies (15, 16) we observed a 20% to 25% reduction in the body weight of male and female Atm −/− mice compared with WT littermates (Fig. 1 A-C) . Male and female Atm −/− Casp2 −/− mice displayed a further 10% to 15% reduction in body weight compared with sex-matched Atm −/− controls ( Fig. 1 A-C) . This additive growth defect was observed before weaning and persisted throughout adulthood. Also, Casp2 −/− mice also displayed a minor growth defect compared with WT mice, although this trend reached statistical significance only in females. Taken together, these data demonstrate that combined loss of caspase-2 and ATM exacerbates growth retardation and causes perinatal lethality in Atm-deficient mice. Although the growth retardation phenotype in Atm −/− mice has been known for many years (15, 16) , the mechanism of such a defect remains unknown. Similarly, examination of Atm
mice did not provide any phenotypic clues to enhanced growth retardation. We noticed that the majority of the Atm
animals at birth were frail and unable to compete for feeding and were routinely culled by their mothers. Thus, although the mechanism of retarded growth remains to be established, the perinatal lethality may simply be a result of weak constitution of some of the Atm
Combined Loss of Caspase-2 and ATM Augments Lymphomagenesis.
We have previously shown that caspase-2 deficiency accelerates lymphomagenesis in Eμ-Myc transgenic mice (5) . Previous reports show that caspase-2 deficiency does not appear to affect tumor development induced by low dose γ-radiation or 3-methylcholanthrene (17) . More recently, it was shown that deletion of caspase-2 in murine mammary tumor virus transgenic mice accelerates tumorigenesis, showing that caspase-2 is also a suppressor of epithelial tumors (18) . To further investigate the tumor suppressor function of caspase-2 specifically in the DDR and oxidative stress pathways, cohorts of Atm −/− and Atm
Casp2 −/− mice were generated and monitored for tumor development over a 1-y period. Under pathogen-free conditions, 12 of 38 Atm −/− mice (31.6%) developed spontaneous tumors with an average onset of 30.8 wk (Fig. 2 A and B) . Notably, loss of caspase-2 dramatically enhanced the incidence of tumorigenesis in 
−/− mice predominately developed lymphomas of the thymus, with no differences observed in the histopathology of these lymphomas between genotypes (Fig. 2C) . We also observed a small proportion of nonthymic lymphomas in both genotypes, which presented as hepatosplenomegaly and tumors of the lymph nodes. WT and Casp2 −/− mice in a C57BL/6 background do not develop spontaneous tumors within 1 y under the same pathogen-free conditions (13) .
Both Atm −/− and Atm −/− Casp2 −/− lymphomas were highly aggressive and infiltrated various secondary sites including the lungs, kidney, liver, and peripheral blood (Fig. S3A) . Peripheral + CD8 + lymphoblastic T cells (also expressing the pan T-cell marker CD90.2; Fig. S4 ). Therefore, although caspase-2 deficiency did not affect the metastatic potential, immunophenotype, or morphology of thymic lymphomas, loss of caspase-2 dramatically increased the incidence of tumorigenesis in Atm −/− mice.
Caspase-2 Deficiency Confers a Proliferative Advantage in Atm
−/− Lymphomas. As caspase-2 has been suggested to contribute to regulation of cell cycle progression (7, 18) and Casp2 −/− MEFs proliferate at a slightly faster rate than their WT counterparts (5, 7), we assessed the proliferative capacity of Atm (Fig. 3B) . These data demonstrate that the loss of caspase-2 does not appear to affect apoptosis but enhances the proliferative capacity of Atm −/− tumors, suggesting that proliferative defects may contribute to the accelerated tumorigenesis observed in Atm 
Casp2
−/− thymic lymphomas were cultured and treated with 5 Gy γ-radiation and the phosphorylation of a number of ATM substrates was assessed by immunoblotting (Fig. S5A) . As expected, in response to dsDNA breaks, activation of downstream effectors involved in DNA repair and cell cycle arrest (Chk1, SMC1, and KAP-1) was significantly ablated in Atm −/− lymphoma cells (Fig. S5A) . However, we did not observe any further impairment in the activation of these proteins in Atm −/− Casp2 −/− lymphoma cells. As the loss of caspase-2 is associated with impaired p53 signaling in MEFs (7), we assessed p53 and p21 protein levels in primary Atm −/− and Atm −/− Casp2 −/− thymic lymphomas. However, we did not observe any differences between the genotypes suggesting that loss of caspase-2 does not affect p53 activity in Atm-deficient tumors (Fig. S5B) . We also examined the extent of cell death and found that apoptosis was rapidly induced at comparable levels in Atm −/− and Atm −/− Casp2 −/− thymic lymphoma cells following treatment with γ-radiation and the ROS inducer menadione (Fig. 3 C and D) . Taken together, these data demonstrate that loss of caspase-2 does not affect DNA damage or ROS-induced apoptosis in Atm −/− tumors in vitro. aneuploid (loss or gain of as many as 9 chromosomes), or highgrade aneuploid (loss or gain of 10 or more chromosomes). It has previously been shown that thymic lymphomas derived from Atm −/− mice are diploid, with a mean chromosome number of 40 (19) . Consistent with this, the majority of metaphases (82.9%) from all Atm −/− thymic lymphomas analyzed showed diploid karyotypes, with only 14.6% and 2.5% of metaphases displaying low-and high-grade aneuploidy, respectively (Fig. 4 A and B and  Fig. S6A ). In contrast, Atm −/−
−/− thymic lymphomas displayed a significant increase in the proportion of metaphases with low-grade (58.9%) and high-grade (13.9%) aneuploidy, which coincided with a marked reduction in the proportion of diploid metaphases (27.2%; Fig. 4 A and B and Fig. S6A ). These observations provide direct evidence that loss of caspase-2 promotes chromosomal instability in vivo.
To further investigate whether loss of genomic stability contributes to the enhanced lymphomagenesis in Atm −/−
−/− mice, we performed cytogenetic analysis on mitogen-activated splenic and thymic T lymphocytes derived from 13 to 14 wk old premalignant mice. Karyotype distributions of Atm −/− splenocytes and thymocytes were indistinguishable from the WT and Casp2 −/− controls (Fig. 4 C  and D and Fig. S6 B and C) . Strikingly, we observed a reduced frequency of diploid metaphases and concomitant increase in the proportion of aneuploid metaphases in Atm −/−
−/− splenocytes and thymocytes compared with Atm −/− controls (Fig. 4 C and D and Fig. S6 B and C ). These observations demonstrate that loss of caspase-2 promotes genomic instability even before tumor onset in Atm −/− mice. Given that we have previously shown that Casp2
−/−
MEFs and lymphomas derived from Eμ-Myc/Casp2 −/− mice display reduced telomere length (7), we performed FISH to assess telomere length in thymic lymphomas. However, we did not observe any significant differences in telomere length or loss between Atm −/− and Atm

Casp2
−/− thymic lymphomas (Fig. S7) , suggesting that telomere dysfunction does not contribute to the chromosome instability in this model.
Increased Oxidative Damage in Atm
−/− Casp2 −/− Lymphomas. Aneuploidy is known to alter cellular energy metabolism and cause increased ROS production (20) . Given that ATM and caspase-2 are known to regulate the oxidative stress response and that Atm −/− Casp2 −/− tumors exhibit extensive aneuploidy, we assessed oxidative damage in thymic lymphomas derived from Atm −/− and Atm −/− Casp2 −/− mice. Protein carbonyls and 8-hydroxy-2-deoxy guanosine are the products of oxidatively modified protein and DNA, respectively, and are robust markers for oxidative damage. We observed significantly increased levels of protein carbonyls and 8-OHdG in Atm
Casp2
−/− thymic lymphomas compared with Atm −/− thymic lymphomas ( Fig. 5 A and B) . Atm-deficient splenocytes and thymocytes displayed increased protein carbonyl levels compared with WT controls (Fig. S8) . However, we did not observe any differences in protein carbonyl levels between Atm −/− and Atm −/− Casp2 −/− splenocytes and thymocytes from premalignant mice (Fig. S8) . These observations imply that the increased oxidative damage observed in Atm −/− Casp2 −/− thymic lymphomas is acquired at the malignant stage, rather than in premalignant cells.
In response to oxidative stress, cells up-regulate a highly conserved network of antioxidant genes to neutralize ROS and prevent oxidative damage (21) . The mitochondrial-localized antioxidant enzymes manganese superoxide dismutase (Sod2), peroxiredoxin III (Prdx3), and catalase (Cat) form an essential axis of these pathways (21) . In addition, cells also up-regulate the stress-responsive genes of the sestrin family to mediate antioxidant defense (22) . Not surprisingly, the increased oxidative stress observed in Atm
tumors coincided with a significant increase in the transcript levels of these antioxidant genes (Fig. 5C ). Although a trend was observed, the difference in Cat levels did not reach statistical significance (Fig. 5C) . Moreover, we also observed increased transcript levels of Sestrin 1 and Sestrin 2, further indicating the presence of elevated oxidative stress in Atm (Fig. 5C ). These results demonstrate that ATM and caspase-2 cooperate to suppress oxidative stress in vivo.
Discussion
In this study, we used Atm −/− mice as a non-oncogene-driven model of spontaneous thymic lymphomagenesis and show that deletion of caspase-2 enhances the incidence of lymphomagenesis in Atm −/− mice. We also observed an increased proliferative capacity, extensive chromosomal instability, and increased oxidative damage in Atm is likely that enhanced growth retardation in the Atm
animals contributes to the lethality in newborn pups. Several studies have reported increased levels of ROS and chronic oxidative stress in tissues from Atm −/− mice (27, 28) . Aged Casp2 −/− mice have also been shown to have an impaired antioxidant defense system and elevated levels of ROS, which is believed to cause premature aging (13, 14) . Therefore, it is possible that combined loss of ATM and caspase-2 exacerbates oxidative damage, leading to enhanced retardation of somatic growth and perinatal lethality in Atm
Casp2
−/− mice. In support of the hypothesis that a poor response to oxidative stress might cause growth retardation, mutation of genes involved in the oxidative stress response have previously been shown to cause developmental retardation in humans (29) .
Given the overlapping functions of ATM and caspase-2 in the DDR, antioxidant defense, and tumor suppression, we hypothesized that deletion of both these genes would accelerate tumorigenesis. Indeed, we show that deletion of caspase-2 dramatically enhanced the incidence of lymphomagenesis in Atm −/− mice. These important findings demonstrate that caspase-2 is a suppressor of not just Myc-driven, but also non-Myc-driven, lymphomagenesis.
Consistent with previous studies (5, 7, 18) , we observed an increased proliferation index in Atm −/− Casp2 −/− tumors, suggesting that caspase-2 deletion, when combined with other oncogenic lesions, confers a proliferative advantage in vivo. Taken together, these data indicate that caspase-2 may function in cell cycle regulation, which may partly contribute to its tumor suppressor function. Importantly, caspase-2 deficiency does not affect DNA double strand break signaling or apoptosis induced by genotoxic and oxidative stress in Atm −/− tumor cells in vitro. Furthermore, we provide evidence that defective cell death pathways or impaired p53 signaling are unlikely to contribute to the increased tumor incidence in Atm In this study, we demonstrate that caspase-2 deficiency is associated with chromosomal instability in vivo. Importantly, we observed increased genomic instability even in premalignant lymphocytes providing further evidence that loss of genomic stability is not merely a consequence, but rather a cause of the enhanced tumorigenesis in Atm −/−
−/− mice. This important finding suggests that caspase-2 may exert its tumor suppressor function through the maintenance of genomic stability. There is strong evidence that aneuploid cells experience proteotoxic stress as a result of imbalances in gene dosage, which leads to the generation of ROS (20) . In line with this, we observed increased oxidative damage to DNA and proteins as assessed by 8-OHdG and protein carbonyl levels, respectively. Interestingly, we did not observe increased oxidative damage in premalignant lymphocytes derived from Atm −/− Casp2 −/− mice compared with Atm −/− controls. Hence, excessive oxidative damage appears to follow aneuploidization and is a phenotype acquired in malignant cells.
Increased levels of ROS is a hallmark of the cancer phenotype, and there is mounting evidence to suggest that cancer cells experiencing oxidative stress undergo extensive reprogramming of mechanisms regulating redox homeostasis (20) . It has been suggested that this reprogramming may represent an adaptive response that maintains ROS levels below a toxic threshold, while still inflicting oxidative damage, thereby permitting survival of tumor cells experiencing chronic oxidative stress (20) . The observed increase in oxidative damage in Atm
tumors coincided with up-regulation of various stress-responsive genes involved in ROS detoxification. Interestingly, a recent study has shown that elevated levels of ROS in aneuploid cells triggers an ATM-dependent response that protects against aneuploidyinduced tumorigenesis (30) . Furthermore, the levels of ROS were shown to be highly correlated with the extent of aneuploidy (30) . Our data further predict that aneuploidy and oxidative damage induced by caspase-2 deficiency in the absence of ATM would allow these damaged cells to acquire additional oncogenic lesions more readily. Furthermore, these observations are consistent with a model by which ATM and caspase-2 operate in parallel tumor suppressor pathways that protect against oxidative stress and aneuploidy (Fig. S9) . Therefore, disruption of these pathways may explain the enhanced incidence of lymphomagenesis in Atm −/− Casp2 −/− mice. One of the major open questions in the field is whether the functions of caspase-2 in the DDR, maintenance of genomic stability, and tumor suppression are solely based on its role in apoptosis, or whether caspase-2 regulates these processes through nonapoptotic mechanisms. Nonetheless, our work here shows that loss of caspase-2 in a sensitized background promotes the acquisition of chromosomal instability and oxidative damage that promotes tumorigenesis. Consistent with these observations, our previous studies demonstrate that, although caspase-2 deficiency renders primary MEFs more susceptible to oncogene-induced transformation and increases the tumorigenic potential of transformed cells, loss of caspase-2 is not sufficient to initiate spontaneous tumorigenesis in vivo (5, 13) . Taken together, these findings provide further evidence that one of the primary functions of this enigmatic caspase is protection against cellular stress conditions that promote tumorigenesis.
Materials and Methods
Mice. All animals were maintained in specific pathogen-free conditions in a 12 h/12 h light/dark cycle and treated in accordance with protocols approved by the SA Pathology/Central Northern Adelaide Health Services Animal Ethics Committee. After weaning at postnatal day 18 to 21, mice were separated 
Casp2
−/− (n = 10) thymic lymphomas. Expression is relative to β-actin levels. Data represented as mean ± SEM (*P < 0.05, **P < 0.01, and ***P < 0.001, Student t test).
